A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments.

In vitro transcribed mRNA has lived up to its potential as a game-changing disruptive vaccine modality during the COVID-19 ...

Moderna (NasdaqGS:MRNA) plans to present Phase 1/2 data for its mRNA-4359 cancer antigen therapy combined with pembrolizumab ...

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help ...

Messenger RNA, or mRNA, vaccine technology burst onto the scene early in the COVID pandemic, leaving many people playing catch-up on the science behind the advance. Within the first six months of ...

Moderna moved its H5N1 vaccine candidate into the first late-stage human trial for a pandemic bird flu shot made with mRNA ...

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology ...

Add Yahoo as a preferred source to see more of our stories on Google. The United States is turning its back on what could be the greatest medical advance in a generation — vaccines made with messenger ...

Messenger RNA technology, better known as mRNA technology, made it possible to rapidly deploy a new vaccine during the COVID-19 pandemic — much earlier than would otherwise have been possible, saving ...

A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now ...